<unk>  is a hepatitis C virus NS3/4A protease inhibitor that is FDA approved for the treatment of chronic hepatitis C (CHC) genotype 1 infection as a component of a combination antiviral treatment regimen.   Common adverse reactions include pruritus, rash, nausea, hyperbilirubinemia, headache, insomnia, and fatigue.
Simeprevir
Boceprevir
Saquinavir
Telaprevir
Fosamprenavir
Abacavir
Entecavir
Tipranavir